News

Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines

Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...

Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments ...
PharmExec1d

Eli Lilly and Company Launch “The Court is Her’s” Initiative Enticing Girls to Play Basketball

Eli Lilly partners with the Indiana Fever and YMCA to empower girls in basketball, removing barriers and promoting community engagement in sports.

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...
PharmExec1d

Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics

Superluminal partners with Eli Lilly to develop AI-driven small molecule therapies targeting GPCRs for obesity and ...

Texas Sues Eli Lilly: 'Big Pharma Compromised Medical Decision-Making'

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
The Daily Reporter9d

Eli Lilly and Co. could get $100 million in state tax credits

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

Eli Lilly insider buying from CEO and others jump amid selloff

Eli Lilly (LLY) stock recovers as company executives seize a rare buying opportunity to make a series of insider purchases ...